Corrigendum to “Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease” [Autoimmunity Reviews - Volume 23, Issue 6, June 2024, 103582]
Guiot J, Miedema J, Cordeiro A, De Vries-Bouwstra J, Dimitroulas T, Søndergaard K, Tzouvelekis A, Smith V. Corrigendum to “Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease” [Autoimmunity Reviews - Volume 23, Issue 6, June 2024, 103582]. Autoimmunity Reviews 2024, 23: 103641. PMID: 39369613, DOI: 10.1016/j.autrev.2024.103641.Peer-Reviewed Original ResearchInterstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations
Sampsonas F, Bosgana P, Bravou V, Tzouvelekis A, Dimitrakopoulos F, Kokkotou E. Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations. Genes 2024, 15: 934. PMID: 39062713, PMCID: PMC11276289, DOI: 10.3390/genes15070934.Peer-Reviewed Original ResearchConceptsInterstitial lung diseaseLung cancerLung diseaseDriver mutationsImproved survivalTreatment optionsChronic inflammationPathogenetic pathwaysNon-small cell lung cancerConcurrent interstitial lung diseaseCell lung cancerSites of chronic inflammationAnti-fibrotic medicationsCurrent treatment optionsIdiopathic pulmonary fibrosisDiseases associated with chronic inflammationIncidence of lung cancerPersonalized medicine approachPrompt diagnosisClinical entityNon-smallPulmonary fibrosisNSCLCSurvival ratePatientsPractical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease
Guiot J, Miedema J, Cordeiro A, De Vries-Bouwstra J, Dimitroulas T, Søndergaard K, Tzouvelekis A, Smith V. Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease. Autoimmunity Reviews 2024, 23: 103582. PMID: 39074630, DOI: 10.1016/j.autrev.2024.103582.Peer-Reviewed Original ResearchInterstitial lung diseaseConnective tissue diseaseConnective tissue disease-related interstitial lung diseaseLung diseaseTissue diseaseCTD-ILDJourney of patientsProgression of interstitial lung diseaseManagement of CTD-ILDComplication of connective tissue diseasesFollow-up of patientsIdentification of interstitial lung diseaseHeterogeneous group of diseasesDisease activity of patientsActivity of patientsPulmonary function testsInternational expert panelGroup of diseasesMultidisciplinary teamExpert panelProgressive diseaseChest radiographyDisease activityClinical examinationFollow-upPresenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies
Tzilas V, Tzouvelekis A, Sotiropoulou V, Panopoulos S, Bouros E, Avdoula E, Ryu J, Bouros D. Presenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies. Frontiers In Medicine 2024, 11: 1392659. PMID: 38711778, PMCID: PMC11070581, DOI: 10.3389/fmed.2024.1392659.Peer-Reviewed Original ResearchMyositis-specific autoantibodiesPresence of myositis-specific autoantibodiesImaging features of patientsChest imaging studiesIdiopathic inflammatory myopathiesFeatures of patientsInterstitial lung diseaseIncreased CK levelsSignificant diagnostic challengeMedian DLCOMedian FVCHRCT patternGottron's papulesUIP patternMedian agePresenting symptomsLung involvementInflammatory myopathiesRadiological featuresDiagnostic challengeMuscle involvementInspiratory cracklesRaynaud's phenomenonComputer-assisted searchLung diseaseMycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis
Lombardi F, Stewart I, Fabbri L, Adams W, Kawano-Dourado L, Ryerson C, Jenkins G, Consortium R, Cavalcanti A, Mojibian A, Bravery A, Goodwin A, Etges A, Boshoff A, Guenther A, Briggs A, Palmer A, Wilson A, Crawshaw A, Anna-MariaHoffmann-Vold A, Holland A, Gordon A, Prasse A, Tzouvelekis A, Trachalaki A, Wells A, Nair A, Wendelberger B, Hope-Gill B, Gooptu B, Baldi B, Crestani B, Polanczyk C, Vancheri C, Robalo C, Summers C, Grainge C, Ryerson C, von Garnier C, Huntley C, Ravaglia C, Valenzuela C, Hayton C, McCarthy C, Chambers D, Wang D, Bablis D, Thicket D, Turner D, Talwar D, Adegunsoye D, Anand D, Dhasmana D, Parek D, Griffiths D, Richards D, Santucci E, Bendstrup E, Balestro E, Tsitoura E, Falaschetti E, Karlsen E, Gupta E, Farrand E, Khan F, Chua F, Martinez F, Bonella F, Lombardi F, Hunninghake G, Saini G, Chalmers G, Jenkins G, Gudmundsson G, Collard H, Parfrey H, Prosch H, Fainberg H, Adamali H, Stewart I, Forrest I, Glaspole I, Bauer-Ventura I, Noth I, Cox I, Strambu I, Sellares J, Eaden J, Johnston J, Swigris J, Blaikley J, Kim J, Chung J, Lasky J, Jacob J, Lee J, Behr J, Storrer K, Negrelli K, Lewandowska K, Johnson K, Antoniou K, Hostettler K, Johannson K, Hurley K, Hett K, Schwarzkopf L, Fabbri L, Price L, Pearmain L, Kawano-Dourado L, Galvin L, Spencer L, Watson L, Crowley L, Richeldi L, Piccari L, Chambour M, Molina-Molina M, Jones M, Spears M, Toshner M, Wijsenbeek-Lourens M, Brutsche M, Vasakova M, Quintana M, Gibbons M, Henry M, Keane M, Kreuter M, Hatieganu M, Sadatsafavi M, Kaminski N, Chaudhuri N, Weatherley N, Hirani N, Babes O, Spagnolo P, Beirne P, Bryce P, George P, Molyneaux P, Ortega P, Crisan-Dabija R, Maida R, Borie R, Lewis R, Rolo R, Guler S, Paganoni S, Singh S, Freitas S, Piciucchi S, Malik S, Barratt S, Hart S, Dal Corso S, Fletcher S, Stanel S, Bianchi S, Jones S, Adams W. Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis. BMJ Open Respiratory Research 2024, 11: e002163. PMID: 38413120, PMCID: PMC10973691, DOI: 10.1136/bmjresp-2023-002163.Peer-Reviewed Original ResearchConceptsInterstitial lung diseaseMycophenolate mofetilRandomised controlled trialsPrimary endpointLung diseasePulmonary functionEfficacy of mycophenolate mofetilPreservation of pulmonary functionInterstitial lung disease diagnosisMMF efficacyPrimary endpoint analysisProspective observational studySystematic reviewNo language restrictionsGrading of RecommendationsAzathioprine efficacyConcomitant steroidsAzathioprine treatmentImmunomodulatory treatmentRandomised controlled trial designSecondary endpointsPlacebo comparatorRetrospective studyAzathioprineSubgroup analysis